(2S,4R)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate, 95.0%, 250mg

3-Amino-2-bromo-4-methylpyridine, 98.0%, 500g

(S)-2-Amino-3-chloropropanoic acid hydrochloride, 95.0%, 10g

(R)-[2,3':1',1'':3'',2'''-Quaternaphthalene]-2',2''-diol, 97%, 1g

3-Amino-4-bromopyrazole, 97.0%, 250g

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(3-chlorophenyl)prop-2-en-1-one, 95.0%, 2g

3-Ethyl-4-methyl-3-pyrrolin-2-one, 97.0%, 25g

Ethyl 5-phenyl-1,3,4-oxadiazole-2-carboxylate, 95.0%, 2.5g

5-Bromoquinoline-8-carboxylic acid, 95.0%, 250mg

4-(((Benzyloxy)carbonyl)amino)butanoic acid, 95.0%, 25g

2-Isopropylthiazole-5-carboxylic acid, 98%, 500mg

1-tert-Butyl 2-methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1,2-dicarboxylate, 95.0%, 250mg

Stachydrin hydrochloride, 20 mg, glass packaging